Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT-Reference-Cited by-同舟云学术

Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT

Published:2023-09-07 Issue:12 Volume:58 Page:1357-1367
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Hernández-Boluda Juan Carlos^ORCID,Eikema Diderik-Jan,Koster Linda,Kröger Nicolaus^ORCID,Robin Marie^ORCID,de Witte Moniek,Finke Jürgen^ORCID,Finazzi Maria Chiara,Broers Annoek,Raida Ludek,Schaap Nicolaas,Chiusolo Patrizia^ORCID,Verbeek Mareike,Hazenberg Carin L. E.,Halaburda Kazimierz,Kulagin Aleksandr^ORCID,Labussière-Wallet Hélène,Gedde-Dahl Tobias,Rabitsch Werner,Raj Kavita^ORCID,Drozd-Sokolowska Joanna^ORCID,Battipaglia Giorgia^ORCID,Polverelli Nicola^ORCID,Czerw Tomasz,Yakoub-Agha Ibrahim^ORCID,McLornan Donal P.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-023-02094-1.pdf

Reference33 articles.

1. Tefferi A. Primary myelofibrosis: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023;98:801–21.

2. Bewersdorf JP, Sheth AH, Vetsa S, Grimshaw A, Giri S, Podoltsev NA, et al. Outcomes of allogeneic hematopoietic cell transplantation in patients with myelofibrosis—a systematic review and meta-analysis. Transpl Cell Ther. 2021;27:873.e1–e13.

3. McLornan D, Eikema DJ, Czerw T, Kroger N, Koster L, Reinhardt HC, et al. Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis. Bone Marrow Transpl. 2021;56:2160–72.

4. Rumi E, Pietra D, Pascutto C, Guglielmelli P, Martinez-Trillos A, Casetti I, et al. Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis. Blood. 2014;124:1062–9.

5. Passamonti F, Mora B, Giorgino T, Guglielmelli P, Cazzola M, Maffioli M, et al. Driver mutations’ effect in secondary myelofibrosis: an international multicenter study based on 781 patients. Leukemia. 2017;31:970–3.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myelofibrosis and allogeneic transplantation: critical points and challenges;Frontiers in Oncology;2024-06-20

2. CALR mutations possess unique prognostic relevance in myelofibrosis—before and after transplant;Bone Marrow Transplantation;2023-10-11